We opened up an opportunity to invest directly into FastWave in mid-2024 and we were blown away by the interest from our community. In fact, we ended up closing $19M in an oversubscribed fundraise in less than a month.
Our next allotment will likely fill up fast, so we highly encourage you to sign up to avoid missing out on the next opportunity to invest.
We opened up an opportunity to invest directly into FastWave in mid-2024 and we were blown away by the interest from our community. In fact, we ended up closing $19M in an oversubscribed fundraise in less than a month.
Our next allotment will likely fill up fast, so we highly encourage you to sign up to avoid missing out on the next opportunity to invest.
Sign up for our exclusive investor waiting list.
Sign up for our exclusive investor waiting list.
"FastWave’s IVL platforms show incredible promise for calcific disease."
Dr. Art Lee
Interventional Cardiologist
"IVL is a phenomenal therapy and FastWave’s systems are very impressive."
Dr. Peter Schneider
Vascular Surgeon
"I’m a big believer in IVL and couldn’t be more excited about FastWave’s systems."
Dr. Amir Kaki
Interventional Cardiologist
"FastWave’s team has rapidly-developed an easy-to-use system to address existing technological gaps."
Dr. Miguel Montero-Baker
Vascular Surgeon
"FastWave’s IVL technology is a promising advancement in calcium modification and I’m excited by their success."
Dr. Venkatesh Ramaiah
Vascular Surgeron
$40M+ raised to date from corporate venture, VCs, and cardiovascular key opinion leaders.
$40M+ raised to date from corporate venture, VCs, and cardiovascular key opinion leaders.
8 successfully treated patients with 100% lesions crossed in first-in-human study.
8 successfully treated patients with 100% lesions crossed in first-in-human study.
$9B+ total addressable intravascular lithotripsy market with only one incumbent.
$9B+ total addressable intravascular lithotripsy market with only one incumbent.
7 patents granted by the USPTO and multiple freedom-to-operate clearances.
7 patents granted by the USPTO and multiple freedom-to-operate clearances.
Led by serial entrepreneurs from Switchback Medical, Joovv, and Medtronic with multiple exits.
Led by serial entrepreneurs from Switchback Medical, Joovv, and Medtronic with multiple exits.
Renowned cardiology and vascular surgery advisory team from Mass General, USCF, UW, and more.
Renowned cardiology and vascular surgery advisory team from Mass General, USCF, UW, and more.
See How You Can Invest in FastWave
We oversubscribed our last round of financing in just a few weeks, so don’t miss out on the next opportunity to invest.
IVL is an impressive therapy with an attractive market and I’m very excited about FastWave’s prospects.
Dr. Puneet Khanna
Interventional Cardiologist & Medtech Investor
See How You Can Invest in FastWave
We oversubscribed our last round of financing in just a few weeks, so don’t miss out on the next opportunity to invest.
IVL is an impressive therapy with an attractive market and I’m very excited about FastWave’s prospects.
Dr. Puneet Khanna
Interventional Cardiologist & Medtech Investor
See How You Can Invest in FastWave
We oversubscribed our last round of financing in just a few weeks, so don’t miss out on the next opportunity to invest.
IVL is an impressive therapy with an attractive market and I’m very excited about FastWave’s prospects.
Dr. Puneet Khanna
Interventional Cardiologist & Medtech Investor
Mailing Address:
FastWave Medical
400 S 4th St, Ste 410
PMB 21892
Minneapolis, MN 55415
Phone:
(833) 888-9283
Email:
team@fastwavemedical.com
Contact
© 2024 FastWave Medical Inc.
Follow FastWave’s Journey
Mailing Address:
FastWave Medical
400 S 4th St, Ste 410
PMB 21892
Minneapolis, MN 55415
Phone:
(833) 888-9283
Email:
team@fastwavemedical.com
Contact
© 2024 FastWave Medical Inc.
Follow FastWave’s Journey
Mailing Address:
FastWave Medical
400 S 4th St, Ste 410
PMB 21892
Minneapolis, MN 55415
Phone:
(833) 888-9283
Email:
team@fastwavemedical.com
Contact
© 2024 FastWave Medical Inc.
Follow FastWave’s Journey